Clinicopathological spectrum of renal parenchymal involvement in B-cell lymphoproliferative disorders
Vincent Javaugue(Université de Poitiers), Frank Bridoux(Université de Poitiers), Cécile Tomowiak(Inserm), Arnaud Jaccard(Centre Hospitalier Universitaire de Limoges), Nathalie Rioux-Leclerc(Centre Hospitalier Universitaire de Rennes), Elise Gand(Université de Poitiers), Éstelle Desport(Centre Hospitalier Universitaire de Poitiers), Xavier Leleu(Inserm), Sophie Chauvet(Assistance Publique – Hôpitaux de Paris), Laure Écotière(Centre National de la Recherche Scientifique), M. Nouvier(Hôpital Lyon Sud), Stéphanie Guidez(Université de Poitiers), Vincent Delwail(Université de Poitiers), Antoine Thierry(Université de Poitiers), Céline Debiais-Delpech, Jean‐Michel Goujon(Centre Hospitalier Universitaire de Poitiers), Cécile Vigneau(Inserm), Guy Touchard(Université de Poitiers), Jean‐Paul Fermand(Sorbonne Université)
Cited by 30
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
|Leukemia|2011|721
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719